
Any licensed influenza vaccine given as indicated for age and health status can be used to protect children against influenza in 2020/2021 season1
SEE 2020/21 AAP RECOMMENDATION
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommended that for the 2020-2021 season, immunization providers may choose to administer any licensed, age-appropriate influenza vaccine (including Live Attenuated Influenza Vaccine (LAIV), Injectable Influenza Vaccine (IIV), and recombinant Injectable Vaccine (RIV). LAIV4 is an option for influenza vaccination for persons for whom it is otherwise appropriate.1
FLUMIST® QUADRIVALENT (Influenza Vaccine Live, Intranasal) is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLUMIST QUADRIVALENT is for intranasal administration only.
The American Academy of Pediatrics (AAP) recommends FLUMIST QUADRIVALENT as a vaccination option for the 2020-2021 influenza season and advises pediatricians to vaccinate their patients against influenza with either the flu shot or the nasal spray vaccine.2
It is important to note that the codes identified below are examples only. Each provider is responsible for ensuring all coding is accurate and documented in the medical record based on the condition of the patient. The use of the following codes does not guarantee reimbursement.
The National Drug Code (NDC) is a universal, unique, 3-segment number identifying drugs by manufacturer, dosage, and package size. Payers may require the submission of the 11-digit NDC on health care claim forms, and electronic claims may be denied for drugs billed without a valid 11-digit NDC. Contact your patient’s health plan to determine claim submission requirements and to determine accurate reporting of NDC codes.
Submitting accurate codes and claims is important to ensure proper reimbursement of services. The chart below lists the potential Current Procedural Terminology (CPT) code for your reference when submitting claims for your FLUMIST QUADRIVALENT patients.
When filing claims, providers often indicate a diagnosis code reflecting the patient’s condition. Based on the Indications for FLUMIST QUADRIVALENT, examples of diagnosis codes that may be appropriate are listed below.
It is important to note that the codes identified below are examples only. Each provider is responsible for ensuring all coding is accurate and documented in the medical record based on the condition of the patient.
The use of the following code does not guarantee reimbursement.
ICD-10-CM=International Classification of Diseases, Tenth Revision, Clinical Modification.
FLUMIST QUADRIVALENT is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLUMIST QUADRIVALENT is for intranasal administration only.
Please see full Prescribing Information for FLUMIST QUADRIVALENT, including Patient Information.
You may report side effects related to AstraZeneca products by clicking here.